Filamentous tau pathology in nerve cells, astrocytes, and oligodendrocytes of aged baboons

Journal of Neuropathology and Experimental Neurology

Volumn 59, Issue 1, 2000, Pages 39-52

  Schultz, Christian ^a   Dehghani, Faramarz ^a   Hubbard, Gene B ^b   Thal, Dietmar R ^a   Struckhoff, Gernot ^c   Braak, Eva ^a   Braak, Heiko ^a  

^a GOETHE UNIVERSITY   (Germany)

^b SOUTHWEST FOUNDATION FOR BIOMEDICAL RESEARCH   (United States)

^c UNIVERSITY OF KIEL   (Germany)

Author keywords

Animal model; Baboon; Nonhuman primates; Tan protein; Tau pathology; Tau positive glial inclusions

Indexed keywords

TAU PROTEIN;

AGING; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BABOON; CYTOPATHOLOGY; CYTOSKELETON; DEGENERATIVE DISEASE; FEMALE; HIPPOCAMPUS; LIMBIC SYSTEM; MALE; NERVE CELL; NEUROFIBRILLARY TANGLE; NEUROPATHOLOGY; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL;

EID: 0033985589     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnen/59.1.39     Document Type: Article

References (67)

1. Braak E, Braak H, Mandelkow EM. A sequence of cytoskeleton changes related to the formation of neurofibrillary tangles and neuropil threads. Acta Neuropathol 1994;87:554-67
2. Goedert M, Spillantini MG, Crowther RA. Tau proteins and neurofibrillary degeneration. Brain Pathol 1991;1:279-86
3. Bergeron C, Davis A, Lang AE. Corticobasal degeneration and progressive supranuclear palsy presenting with cognitive decline. Brain Pathol 1998;8:355-65
4. Dickson DW. Pick's disease: A modern approach. Brain Pathol 1998;8:339-54
5. Braak H, Braak E. Involvement of precerebellar nuclei in Pick's disease. Exp Neurol 1988;152:351-65
6. Feany MB, Dickson DW. Neurodegenerative disorders with extensive tau pathology: A comparative study and review. Ann Neurol 1996;40:139-48
7. Braak H, Braak E. Argyrophilic grain disease: frequency of occurrence in different age categories and neuropathological diagnostic criteria. J Neural Transm 1998;105:801-19
8. Jellinger KA. Dementia with grains (argyrophilic grain disease). Brain Pathol 1998;8:377-86
9. Feany MB, Mattiace LA, Dickson DW. Neuropathologic overlap of progressive supranuclear palsy, Pick's disease and corticobasal degeneration. J Neuropathol Exp Neurol 1996;55:53-67
10. Chin SS-M, Goldman J. Glial inclusions in CNS degenerative diseases. J Neuropathol Exp Neurol 1996;55:499-508
11. Ikeda K, Akiyama H, Arai T, Nishimura T. Glial tau pathology in neurodegenerative diseases: Their nature and comparison with neuronal tangles. Neurobiol Aging 1998;19:S85-S91
12. Foster NL, Wilhelmsen K, Sima AA, Jones MZ, D'Amato CJ, Gilman S. Frontotemporal dementia and parkinsonism linked to chromosome 17: A consensus conference. Ann Neurol 1997;41:706-15
13. Spillantini MG, Bird TD, Ghetti B. Frontotemporal dementia and Parkinsonism linked to chromosome 17: A new group of tauopathies. Brain Pathol 1998;8:387-402
14. Hutton M, Lendon CL, Rizzu P, et al. Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 1998;393:702-5
15. Hong M, Zhukareva V, Vogelsberg-Ragaglia V, et al. Mutation-specific functional impairments in distinct tau isoforms of hereditary FTDP-17. Science 1989;282:1914-17
16. Cork LC, Powers RE, Selkoe D, Davies P, Geyer JJ, Price DL. Neurofibrillary tangles and senile plaques in aged bears. J Neuropathol Exp Neurol 1988;47:629-41
17. Braak H, Braak E, Strothjohann M. Abnormally phosphorylated tau protein related to the formation of neurofibrillary tangles and neuropil threads in the cerebral cortex of sheep and goat. Neurosci Lett 1994;171:1-4
18. Nelson PT, Greenberg SG, Saper CB. Neurofibrillary tangles in the cerebral cortex of sheep. Neurosci Lett 1994;170:187-90
19. Nelson PT, Saper CB. Ultrastructure of neurofibrillary tangles in the cerebral cortex of sheep. Neurobiol Aging 1995;16:315-23
20. Roertgen KE, Parisi JE, Clark HB, Barnes DL, O'Brien TD, Johnson KH. Aβ-associated cerebral angiopathy and senile plaques with neurofibrillary tangles and cerebral hemorrhage in an aged wolverine (Gulo gulo). Neurobiol Aging 1996;17:243-47
21. Peters A, Rosene DL, Moss MB, et al. Neurobiological bases of age-related cognitive decline in the rhesus monkey. J Neuropathol Exp Neurol 1996;55:861-74
22. Gearing M, Rebeck GW, Hyman BT, Tigges J, Mirra SS. Neuropathology and apolipoprotein E profile of aged chimpanzees: Implications for Alzheimer's disease. Proc Natl Acad Sci (USA) 1994;91:9382-86
23. Poduri A, Gearing M, Rebeck GW, Mirra SS, Tigges J, Hyman BT. Apolipoprotein E4 and beta amyloid in senile plaques and cerebral blood vessels of aged rhesus monkeys. Am J Pathol 1994;144: 1183-87
24. Uno H, Alsum PB, Dong S, et al. Cerebral amyloid angiopathy and plaques, and visceral amyloidosis in aged macaques. Neurobiol Aging 1996;17:275-81
25. Braak H, Braak E. Demonstration of amyloid deposits and neurofibrillary changes in whole brain sections. Brain Pathol 1991;1: 213-16
26. Braak H, Braak E, Ohm TG, Bohl J. Silver impregnation of Alzheimer's neurofibrillary changes counterstained for basophilic material and lipofuscin pigment. Stain Technol 1988;63:197-200
27. Gallyas F. Silver staining of Alzheimer's neurofibrillary changes by means of physical development. Acta Morphol Acad Sci Hung 1971;19:1-8
28. Mercken M, Vandermeeren M, Lübke U, et al. Monoclonal antibodies with selective specificity for Alzheimer tau are directed against phosphatase-sensitive epitopes. Acta Neuropathol 1992;84: 265-72
29. Biernat J, Gustke N, Drewes G, Mandelkow EM, Mandelkow E. Phosphorylation of serine 262 strongly reduces the binding of tau protein to microtubules: Distinction between PHF-like immunoreactivity and microtubule binding. Neuron 1993;11:153-63
30. Goedert M, Jakes R, Crowther RA, et al. Epitope mapping of monoclonal antibodies to the paired helical filaments of Alzheimer's disease: Identification of phosphorylation sites in tau protein. Biochem J 1994;301:871-77
31. Goedert M, Jakes R, Vanmechelen E. Monoclonal antibody AT8 recognizes tau protein phosphorylated at both serine 202 and threonine 205. Neurosci Lett 1995;189:167-70
32. Greenberg SG, Davies P, Schein JD, Binder LI. Hydrofluoric acid-treated tau/PHF proteins display the same biochemical properties as normal tau. J Biol Chem 1992;267:564-69
33. Jicha GA, Lane E, Vincent I, Otvos L, Hoffmann R, Davies P. A conformation-and phosphorylation-dependent antibody recognizing the paired helical filaments of Alzheimer's disease. J Neurochem 1997;69:2087-95
34. Wolozin BL, Pruchnicki A, Dickson DW, Davies P. A neuronal antigen in the brains of Alzheimer's patients. Science 1986;232: 648-50
35. Ksiezak-Reding H, Chien CH, Lee VMY, Yen SH. Mapping of the Alz-50 epitope in microtubule associated proteins tau. J Neurosci Res 1990;25:412-19
36. Grundke-Iqbal I, Vorbrodt AW, Iqbal K, Tung Y-C, Wang GP, Wisniewski HM. Microtubule-associated peptides are altered in Alzheimer paired helical filaments. Mol Brain Res 1988;4:43-52
37. Iqbal K, Braak H, Braak E, Grundke-Iqbal I. Silver labeling of Alzheimer neurofibrillary changes and brain β-amyloid. J Histotechnol 1993;16:335-42
38. Braak H, Braak E. Cortical and subcortical argyrophilic grains characterise a disease associated with adult onset dementia. Neuropathol Appl Neurobiol 1989;15:13-26
39. Yamada T, McGeer PL. Oligodendroglial microtubular masses: An abnormality observed in some human neurodegenerative diseases. Neurosci Lett 1990;120:163-66
40. Goedert M. Neurofibrillary pathology in Alzheimer's disease and other tauopathies. Prog Brain Res 1998;117:287-306
41. Otvos LJ, Feiner L, Lang E, Szendrei GI, Goedert M, Lee VM-Y. Monoclonal antibody PHF-1 recognizes tau protein phosphorylated at serine residues 396 and 404. J Neurosci Res 1994;39:669-73
42. Binder LI, Frankfurter A, Rebhun LI. The distribution of tau in the mammalian central nervous system. J Cell Biology 1985;101: 1371-78
43. Goedert M, Hasegawa M. The tauopathies. Toward an experimental animal model. Am J Pathol 1999;154:1-6
44. Bancher C, Brunner C, Lassmann H, et al. Accumulation of abnormally phosphorylated τ precedes the formation of neurofibrillary tangles in Alzheimer's disease. Brain Res 1989;477:90-99
45. Gearing M, Tigges J, Mori H, Mirra SS. τ-Amyloid (Aτ) deposition in the brains of aged orangutans. Neurobiol Aging 1997;18: 139-46
46. Wisniewski HM, Ghetti B, Terry R. Neuritic (senile) plaques and filamentous changes in aged rhesus monkeys. J Neuropathol Exp Neurol 1973;32:566-84
47. Struble RG, Price DL, Cork L, Price DL. Senile Plaques in cortex of aged normal monkeys. Brain Res 1985;361:267-75
48. Selkoe DJ, Bell DS, Podlinski MB, Price DL, Cork LC. Conservation of brain amyloid proteins in aged mammals and humans with Alzheimer's disease. Science 1987;235:873-77
49. Cork LC, Walker LC, Price DL. Neurofibrillary tangles and senile plaques in cognitively impaired, aged nonhuman primates. (Abstract) J Neuropathol Exp Neurol 1989;48:378
50. Spillantini MG, Goedert M, Crowther RA, Murrell JR, Farlow MR, Ghetti B. Familial multiple system tauopathy with presenile dementia: a disease with abundant neuronal and glial tau filaments. Proc Natl Acad Sci USA 1997;94:4113-18
51. Spillantini MG, Murrell JR, Goedert M, Farlow MR, Klug A, Ghetti B. Mutation in the tau gene in familial system tauopathy with presenile dementia. Proc Natl Acad Sci USA 1998;95:7737-41
52. Hauw J-J, Daniel SE, Dickson DW, et al. Preliminary NINDS neuropathologic criteria for Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy). Neurology 1994;44:2015-19
53. Geula C, Wu CK, Saroff D, Lorenzo A, Yuan M, Yankner BA. Aging renders the brain vulnerable to amyloid β-protein neurotoxicity. Nature Med 1998;4:827-31
54. Sturchler-Pierrat C, Abramowski D, Duke M, et al. Two amyloid precursor transgenic mouse models with Alzheimer disease-like pathology. Proc Natl Acad Sci (USA) 1997;94:13287-92
55. Brion JP, Tremp G, Octave JN. Transgenic expression of the shortest human tau affects ist compartmentalization and ist phosphorylation as in the pretangle stage of Alzheimer's disease. Am J Pathol 1999;154:255-70
56. Götz J, Probst A, Spillantini MG, et al. Somatodendritic localization and hyperphosphorylation of tau protein in transgenic mice expressing the longest human brain tau isoform. EMBO J 1995;14: 1304-13
57. Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 1991;82:239-59
58. Tolnay M, Spillantini MG, Goedert M, Ulrich J, Langui D, Probst A. Argyrophilic grain disease: widespread hyperphosphorylation of tau protein in limbic neurons. Acta Neuropathol 1997;93:477-84
59. Botez G, Probst A, Ipsen S, Tolnay M. Astrocytes expressing hyperphosphorylated tau protein without glial fibrillary tangles in argyrophilic grain disease. Acta Neuropathol 98:251-56
60. Schultz C, Koppers D, Sassin I, Braak E, Braak H. Cytoskeletal alterations in the human tuberal hypothalamus related to argyrophilic grain disease. Acta Neuropathol. 1998;96:596-602
61. Ghebremedhin E, Schultz C, Botez G, et al. Argyrophilic grain disease is associated with apolipoprotein E ∈ 2 allele. Acta Neuropathol 1998;96:222-24
62. Dickson DW. Astrocytes in other neurodegenerative diseases. In: Schipper HM, ed. Astrocytes in Brain Aging and Neurodegeneration. Austin, Texas: RG Landes, 1998:165-88
63. Sloane JA, Pietrapaolo MF, Rosene DL, et al. Lack of correlation between plaque burden and cognition in the aged monkey. Acta Neuropathol 1997;94:471-78
64. Heilbronner PL, Kemper TL. The cytoarchitectonic distribution of senile paques in three aged monkeys. Acta Neuropathol 1990;81: 60-65
65. Hardy J. Amyloid, the presenilins and Alzheimer's disease. TINS 1997;20:154-59
66. Selkoe DJ. Translating cell biology into therapeutic advances in Alzheimer's disease. Nature 1999;399 (Supp) A23-A31
67. Walker LC, Kitt CA, Schwam E, et al. Senile plaques in aged squirrel monkeys. Neurobiol Aging 1987;8:291-96